GlassScriptPhysician profile
Marena L Shaw
NPI 1932332889
$1,382.77
in general payments reported to CMS, 2019-2025
10 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $417 · 2022: $110 · 2023: $187 · 2024: $321 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $301.02 | 2022-2025 | Lifevest |
| Amgen INC. | $254.27 | 2021-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $164.43 | 2021-2023 | |
| Heartflow, INC. | $152.80 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $126.86 | 2021 | |
| Abbott Laboratories | $125.02 | 2021-2023 | Cardiomems |
| Boston Scientific Corporation | $124.00 | 2021 | |
| Recor Medical INC | $83.97 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Janssen Pharmaceuticals, INC | $36.64 | 2021-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marena Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.